Historical record - last NADAC effective date: 1/4/2017
Product Information
OSENI 25-45 MG TABLET is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $12.0589 per EA under NDC 64764025403. Its NADAC has been published 152 times since Feb 18, 2015.
FDA first approved this application on Jan 25, 2013.
Strength
25; 45 mg/1; mg/1
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
64764025403
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
1/4/2017
Active Ingredients
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA022426FDA Approved
1/25/2013
On Market Since
1/25/2013
Pharmacological Classes
Price Statistics
The NADAC for OSENI 25-45 MG TABLET has been published 152 times since Feb 18, 2015, and over the history we have for it it has risen 20.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.0589 per EA |
|---|---|
| All-time high | $12.0589 (Jan 10, 2018) |
| All-time low | $9.7665 (Jun 17, 2015) |
| Median price | $11.7078 |
| Average price | $11.4035 |
| Largest weekly change | +9.9% (Aug 12, 2015) |
| Weeks tracked | 152 |
| Tracking since | Feb 18, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+20.6%
Last surveyed Jan 10, 2018 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the alogliptin and pioglitazone market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Takeda Pharmaceuticals America, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
alogliptin and pioglitazone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dipeptidyl Peptidase 4 Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OSENI 25-45 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OSENI 25-45 MG TABLET, manufactured by Takeda Pharmaceuticals America, Inc., is $12.0589 per EA (NDC 64764025403), effective Jan 10, 2018.
How has the price of OSENI 25-45 MG TABLET changed over time?
Over the history we have for it, the NADAC for OSENI 25-45 MG TABLET has risen 20.6%. It has been tracked across 152 weekly CMS publications since Feb 18, 2015.
What are the highest and lowest recorded NADAC prices for OSENI 25-45 MG TABLET?
Since Feb 18, 2015, the NADAC for OSENI 25-45 MG TABLET has ranged from a low of $9.7665 (Jun 17, 2015) to a high of $12.0589 (Jan 10, 2018), with a median of $11.7078 per EA.
Are there cheaper alternatives to OSENI 25-45 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of OSENI 25-45 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OSENI 25-45 MG TABLET?
OSENI 25-45 MG TABLET (NDC 64764025403) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.